← Leaderboards
Mark Kuei-Chun Wang
University Of California, San Diego
$1,419,544
Attributed
$1,419,544
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $408K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,419,544 · 3
By mechanism
R00$739,841 · 1
R56$407,975 · 1
K99$271,728 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Louise Chang Laurent$25,039,144
- Michael J Sailor$3,905,383
- Chunru Lin$7,032,732
- Linda Kathleen McEvoy$15,921,659
- Gen-Sheng Feng$26,576,336
Others in their field
Other Emerging Leaders on “Play”
- Chanza Baytop · Westat, Inc.$271,217,917
- John E West · University Of Texas At Austin$97,000,000
- Scott Topper · Broad Institute, Inc.$40,042,399
- Priyamvada Acharya · Duke University$22,519,941
- Bronwen Shaw · Medical College Of Wisconsin$19,560,999
- Oliver Brand · Emory University$18,288,469
Research focus
PlayBlood PlateletsIn VivoPhenotypeRegulationTissuesInflammatoryIn VitroMouse ModelNovel StrategiesCellsPreventResearch Project GrantsSiteAttenuatedHemodynamicsBlood VesselsInvestigationLesionMembraneNanoparticleBlood FlowAtherosclerosisAtheroprotective
Grant awards (6)
Development of lesion-targeted lncRNA nanotherapeutic for vascular smooth muscle dysfunction$407,975
R56 · FY2024 · HL · contact PI
Flow Regulation of YAP/TAZ in Atherogenesis and Therapeutic Development$248,980
R00 · FY2022 · HL · contact PI
Flow Regulation of YAP/TAZ in Atherogenesis and Therapeutic Development$241,862
R00 · FY2021 · HL · contact PI
Flow Regulation of YAP/TAZ in Atherogenesis and Therapeutic Development$248,999
R00 · FY2020 · HL · contact PI
Flow Regulation of YAP/TAZ in Atherogenesis and Therapeutic Development$135,864
K99 · FY2018 · HL · contact PI
Flow Regulation of YAP/TAZ in Atherogenesis and Therapeutic Development$135,864
K99 · FY2017 · HL · contact PI